DSM Strategy Update
DSM Strategy Update |
[20-June-2018] |
HEERLEN, the Netherlands, June 20, 2018 /PRNewswire/ -- Royal DSM, a global science-based company, today presents its strategy update entitled "Growth & Value - Purpose led, Performance driven." at its Capital Markets Day in London (UK). (Logo: https://mma.prnewswire.com/media/657851/DSM_Logo.jpg )
Feike Sijbesma, CEO/Chairman DSM Managing Board, commented: "Our Strategy 2015-18 has been highly successful. After transforming DSM over the period 2010-15, we delivered strong growth with greatly improved operational and financial performance and significant value creation in all our businesses. In addition, we took important steps to monetize our non-core Pharma and Bulk Chemicals joint ventures. DSM has become a growth company with ambitious sustainability efforts creating value for all stakeholders across the three dimensions of People, Planet and Profit. DSM will evolve further towards a purpose-led, science-based company in Nutrition, Health and Sustainable Living. We have created a strong platform for growth, centered on developing innovative solutions addressing Nutrition & Health, Climate & Energy and Resources & Circularity. Increased customer centricity and large innovation projects will enable above-market growth, while we will remain focused on cost control and operational excellence, allowing us to accelerate profit and cash generation. Organic growth will be complemented by acquisitions predominantly in Nutrition. I am convinced that our strategy will create further significant value for all our stakeholders and the step-up in the dividend demonstrates our confidence in the future." DSM's strategy update Purpose sets scope for further growth and evolution
Performance driven to deliver growth and value Ambitious targets for profit growth and cash generation to drive value creation
Financial targets to be supported by holistic value-creation approach
Step-up in dividend linked to underlying earnings growth
Cash allocation policy remains unchanged
Video-webcast and presentations A conference call for the media will be held at 08.30 hrs. (CET). Details on how to access this call can be requested at media.contacts@dsm.com. The DSM Capital Markets Day can be followed live via Video webcast from 10.00 -14.00 hrs. (CET). The presentations can be found on http://www.dsm.com as from 09.45 hrs. (CET). DSM - Bright Science. Brighter Living.™ Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company is listed on Euronext Amsterdam. More information can be found at http://www.dsm.com . Or find us on: https://www.facebook.com/DSMcompany Forward-looking statements This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
For more information:
PRN NLD | ||
Company Codes: EuronextAmsterdam:DSM, OTC-PINK:RDSMY, Bloomberg:DSM@NA, ISIN:NL0000009827 |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}XPeng (NYSE: XPEV) Unveils Beta Version Navigation Guided Pilot Function




